Biostatistics and Bioinformatics Shared Resource Facility
生物统计学和生物信息学共享资源设施
基本信息
- 批准号:10204885
- 负责人:
- 金额:$ 23.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-08 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAppalachian RegionApplications GrantsAreaBasic ScienceBioinformaticsBioinformatics Shared ResourceBiologicalBiological MarkersBiometryCancer CenterCancer Center Support GrantCancer ControlCancer Surveillance ResearchCell SeparationCellular biologyClassificationClinicalClinical Cancer CenterClinical ResearchClinical TrialsCollaborationsCommunitiesCommunity OutreachComprehensive Cancer CenterComputer softwareConsultationsDataData AnalysesData ScienceDatabasesDevelopmentDiseaseDoseEarly Therapeutic-Clinical Trials NetworkEducationEducation and OutreachEnsureEpigenetic ProcessEvaluationExperimental DesignsFacultyFlow CytometryFundingGenomic InstabilityGenomicsGrantGrowthHandHuman ResourcesImmunologic MonitoringInformaticsJournalsKentuckyLeadLeadershipMalignant neoplasm of lungMalignant neoplasm of pancreasMentorsMentorshipMetabolismMethodologyMethodsMissionModelingMolecularMonitorMulticenter TrialsNCI Center for Cancer ResearchNational Cancer InstituteOxidation-ReductionPathologyPeer ReviewPlayPopulationPopulation ResearchPopulation StudyPositioning AttributePrecision medicine trialProcessQuality ControlReproducibilityResearchResearch DesignResearch PersonnelResearch PriorityResearch SupportResource SharingResourcesRisk FactorsRoleSample SizeScienceSeriesService provisionServicesSignal TransductionSiteStatistical Data InterpretationStatistical MethodsSurvival AnalysisTechnical ExpertiseTestingTherapeuticToxic effectTrainingTraining ActivityTraining ProgramsTraining and EducationTranslational ResearchUniversitiesWorkWritinganticancer researchbasebiomarker-drivencancer cellcancer health disparitycancer immunotherapycancer preventioncomputerized data processingcost effectivedata analysis pipelinedata managementdata qualitydesigndrug discoveryearly phase clinical trialearly phase trialexosomeexperiencegenomic platformhealth disparityhigh throughput analysisimprovedinnovationinvestigator-initiated triallecturesmalignant breast neoplasmmeetingsmembermetabolomicsmultidisciplinaryneoplasm registrynext generation sequencingnovelpopulation basedprecision medicineprecision medicine clinical trialsprogramsresearch studyskillsstatisticssuccesstargeted treatmenttranslational clinical trialtranslational studytumor immunologyworking group
项目摘要
PROJECT SUMMARY/ABSTRACT
The Biostatistics and Bioinformatics Shared Resource Facility (BB SRF) is an essential cancer center-
managed resource and has played a critical role as members in team science by providing statistical and
bioinformatics expertise to enable and enhance the Markey Cancer Center’s (MCC) basic, clinical and
population research. BB SRF services are categorized broadly into: 1) study planning, power and sample size
calculations for grant applications; 2) design and implementation support for clinical trials; 3) statistical
analyses, including interim and final analysis for the entire spectrum of cancer research studies; 4)
bioinformatics methods for design and analysis of high-throughput ’omics data; 5) statistical programming for
data quality control and data processing; and 6) mentoring, education and general consultation to MCC
investigators. BB SRF services are coordinated with other MCC SRFs with hand-offs and integrated workflows
to ensure comprehensive, seamless and non-overlapping support. During the current funding cycle, the BB
SRF has made significant scientific impact by employing technical methodologies directly supporting MCC
Research Program themes. These technical methodologies include development and implementation of state-
of-the-art data processing and data analysis pipelines and software for several genomic platforms with specific
applications to Kentucky’s Appalachian population; novel differential analysis and classification methodologies
for metabolomics and exosome data for lung, breast and pancreas cancers; adaptive and model-based dose
finding designs and state-of-the art designs for early phase trials with biomarker and genomic evaluations of
targeted therapies; statistical methodologies for population-based cancer prevention studies including
nonparametric estimation and hypothesis testing of risk factor distributions, relative survival estimation and
statistical methods for cancer registry and large claims databases to support research in MCC’s research in
health disparities. In addition to support as co-investigators in 52 newly funded grants and over 40 investigator-
initiated trials, BB SRF faculty engaged in novel methodological work to enhance the science of MCC
Research Programs. During the current CCSG funding cycle, the BB SRF supported 128 MCC members (81
peer-reviewed funded) from all 4 MCC Research Programs, representing 74% coverage from the total MCC
membership.
The BB SRF has significantly increased usage and value added metrics, expanded its services and has
grown in personnel from 8 faculty and staff to a current total of 14 to address the growth and emerging
research directions of the MCC. The highly experienced personnel and diverse skill set of the BB SRF adds
significant value to the execution of scientifically rigorous research at the MCC and demonstrates that the BB
SRF is well positioned to support the MCC as a Comprehensive Cancer Center for the Commonwealth of
Kentucky in this renewal application.
项目总结/摘要
生物统计学和生物信息学共享资源设施(BB SRF)是一个重要的癌症中心-
管理资源,并通过提供统计和
生物信息学专业知识,使和加强马基癌症中心(MCC)的基础,临床和
人口研究。BB SRF服务大致分为:1)研究计划、把握度和样本量
资助申请的计算; 2)临床试验的设计和实施支持; 3)统计
分析,包括整个癌症研究范围的中期和最终分析; 4)
用于设计和分析高通量组学数据的生物信息学方法; 5)
数据质量控制和数据处理;以及6)对MCC进行指导、教育和一般咨询
investigators. BB SRF服务通过交接和综合工作流程与其他MCC SRF协调
确保全面、无缝且不重叠的支持。在当前的供资周期内,BB
战略成果框架通过采用直接支持千年挑战委员会的技术方法,
研究计划主题。这些技术方法包括制定和实施国家-
最先进的数据处理和数据分析管道和软件,用于具有特定功能的多个基因组平台
应用于肯塔基州的阿巴拉契亚人口;新的差异分析和分类方法
用于肺癌、乳腺癌和胰腺癌的代谢组学和外泌体数据;自适应和基于模型的剂量
发现设计和最先进的设计,用于早期试验,包括生物标志物和基因组评价,
靶向治疗;基于人群的癌症预防研究的统计方法,包括
风险因子分布的非参数估计和假设检验,相对生存估计,
癌症登记处和大型索赔数据库的统计方法,以支持MCC的研究,
健康差距。除了作为共同调查员在52项新供资的赠款和40多名调查员中提供支助外,
启动试验后,BB SRF教师从事新颖的方法学工作,以增强MCC的科学性
研究计划。在当前的CCSG供资周期内,BB SRF支持了128个管理协委会成员(81
来自所有4个MCC研究计划的同行评审资助),占MCC总覆盖率的74%
会员资格
BB SRF显著提高了使用率和增值指标,扩展了服务,
人员从8名教职员工增加到目前的14名,以解决增长和新兴的
MCC的研究方向。BB SRF经验丰富的人员和多样化的技能组合增加了
对MCC进行科学严谨的研究具有重大价值,并表明BB
SRF有能力支持MCC成为英联邦的综合癌症中心。
肯塔基州在此更新申请。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heidi L Weiss其他文献
Heidi L Weiss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heidi L Weiss', 18)}}的其他基金
Biostatistics and Bioinformatics Shared Resource Facility
生物统计学和生物信息学共享资源设施
- 批准号:
10470104 - 财政年份:2013
- 资助金额:
$ 23.35万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 23.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 23.35万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 23.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.35万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 23.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.35万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 23.35万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 23.35万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 23.35万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 23.35万 - 项目类别:
Standard Grant














{{item.name}}会员




